PRINCETON, N.J., Sept. 22, 2014 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq:AGRX) a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, today announced that Al Altomari, President and Chief Executive Officer, will present a business overview and update at BioCentury's 21st Annual NewsMakers Conference. The presentation will be held on Friday, September 26, 2014 at 2:30 PM Eastern Time in New York.
A live audio webcast of the presentation will be accessible on the Investors page of the Company's website at www.agiletherapeutics.com under Investor Relations, Events and Webcasts. A replay of the presentation will be made available. Investors interested in listening to the live webcast should log on before the start time to download any required software.
Agile Therapeutics is a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products. Our product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. Our lead product candidate, Twirla, (ethinyl estradiol and levonorgestrel transdermal system), also known as AG200-15, is a once-weekly prescription contraceptive patch currently in Phase 3 clinical development. Twirla is based on our proprietary transdermal patch technology, called Skinfusion®, which is designed to provide advantages over currently available patches and is intended to optimize patch adherence and patient acceptability. For more information, please visit the company website at www.agiletherapeutics.com.
CONTACT: Mary Coleman (609) 683-1880Source:Agile Therapeutics